{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T03:46:26Z","timestamp":1767152786222,"version":"build-2238731810"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,9,14]],"date-time":"2015-09-14T00:00:00Z","timestamp":1442188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,9,14]],"date-time":"2015-09-14T00:00:00Z","timestamp":1442188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Amino acid (aa) polymorphisms in the hepatitis C virus (HCV) genotype 1b core protein have been reported to be a potent predictor for poor response to interferon (IFN)-based therapy and a risk factor for hepatocarcinogenesis. We investigated the effects of these polymorphisms with genotype 1b\/2a chimeric viruses that contained polymorphisms of Arg\/Gln at aa 70 and Leu\/Met at aa 91. We found that infectious virus production was reduced in cells transfected with chimeric virus RNA that had Gln at aa 70 (aa70Q) compared with RNA with Arg at aa 70 (aa70R). Using flow cytometry analysis, we confirmed that HCV core protein accumulated in aa70Q clone transfected cells and it caused a reduction in cell-surface expression of major histocompatibility complex (MHC) class I molecules induced by IFN treatment through enhanced protein kinase R phosphorylation. We could not detect any effects due to the polymorphism at aa 91. In conclusion, the polymorphism at aa 70 was associated with efficiency of infectious virus production and this deteriorated virus production in strains with aa70Q resulted in the intracellular accumulation of HCV proteins and attenuation of MHC class I molecule expression. These observations may explain the strain-associated resistance to IFN-based therapy and hepatocarcinogenesis of HCV.<\/jats:p>","DOI":"10.1038\/srep13994","type":"journal-article","created":{"date-parts":[[2015,9,14]],"date-time":"2015-09-14T05:27:47Z","timestamp":1442208467000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Amino Acid Polymorphisms in Hepatitis C Virus Core Affect Infectious Virus Production and Major Histocompatibility Complex Class I Molecule Expression"],"prefix":"10.1038","volume":"5","author":[{"given":"Megumi","family":"Tasaka-Fujita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nao","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wonseok","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asako","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norie","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senko","family":"Tsukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Watashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Asahina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaji","family":"Wakita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eui-Cheol","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanobu","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,14]]},"reference":[{"key":"BFsrep13994_CR1","doi-asserted-by":"publisher","first-page":"296","DOI":"10.7326\/0003-4819-132-4-200002150-00008","volume":"132","author":"TJ Liang","year":"2000","unstructured":"Liang, T. J., Rehermann, B., Seeff, L. B. & Hoofnagle, J. H. Pathogenesis, natural history, treatment and prevention of hepatitis C. Ann. Intern. Med. 132, 296\u2013305 (2000).","journal-title":"Ann. Intern. Med."},{"key":"BFsrep13994_CR2","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/s1473-3099(05)70216-4","volume":"5","author":"CW Shepard","year":"2005","unstructured":"Shepard, C. W., Finelli, L. & Alter, M. J. Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 5, 558\u2013567, 10.1016\/s1473-3099(05)70216-4 (2005).","journal-title":"Lancet Infect. Dis."},{"key":"BFsrep13994_CR3","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1056\/NEJM198612183152503","volume":"315","author":"JH Hoofnagle","year":"1986","unstructured":"Hoofnagle, J. H. et al. Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report. N. Engl. J. Med. 315, 1575\u20131578, 10.1056\/NEJM198612183152503 (1986).","journal-title":"N. Engl. J. Med."},{"key":"BFsrep13994_CR4","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/hep.22759","volume":"49","author":"MG Ghany","year":"2009","unstructured":"Ghany, M. G., Strader, D. B., Thomas, D. L., Seeff, L. B. & American Association for the Study of Liver, D. Diagnosis, management and treatment of hepatitis C: an update. Hepatology 49, 1335\u20131374, 10.1002\/hep.22759 (2009).","journal-title":"Hepatology"},{"key":"BFsrep13994_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1365-2893.2008.01012.x","volume":"16","author":"S Zeuzem","year":"2009","unstructured":"Zeuzem, S. et al. Expert opinion on the treatment of patients with chronic hepatitis C. J. Viral Hepat. 16, 75\u201390, 10.1111\/j.1365-2893.2008.01012.x (2009).","journal-title":"J. Viral Hepat."},{"key":"BFsrep13994_CR6","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1159\/000086064","volume":"48","author":"N Akuta","year":"2005","unstructured":"Akuta, N. et al. Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy. Intervirology 48, 372\u2013380, 10.1159\/000086064 (2005).","journal-title":"Intervirology"},{"key":"BFsrep13994_CR7","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1007\/s00535-009-0087-x","volume":"44","author":"T Okanoue","year":"2009","unstructured":"Okanoue, T. et al. Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study. J. Gastroenterol. 44, 952 -963, 10.1007\/s00535-009-0087-x (2009).","journal-title":"J. Gastroenterol."},{"key":"BFsrep13994_CR8","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/jmv.21438","volume":"81","author":"N Mori","year":"2009","unstructured":"Mori, N. et al. Randomized trial of high-dose interferon-alpha-2b combined with ribavirin in patients with chronic hepatitis C: Correlation between amino acid substitutions in the core\/NS5A region and virological response to interferon therapy. J. Med. Virol. 81, 640\u2013649, 10.1002\/jmv.21438 (2009).","journal-title":"J. Med. Virol."},{"key":"BFsrep13994_CR9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1159\/000252787","volume":"53","author":"N Enomoto","year":"2010","unstructured":"Enomoto, N. & Maekawa, S. HCV genetic elements determining the early response to peginterferon and ribavirin therapy. Intervirology 53, 66\u201369, 10.1159\/000252787 (2010).","journal-title":"Intervirology"},{"key":"BFsrep13994_CR10","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jhep.2009.10.001","volume":"52","author":"S Nakamoto","year":"2010","unstructured":"Nakamoto, S. et al. Association between mutations in the core region of hepatitis C virus genotype 1 and hepatocellular carcinoma development. J. Hepatol. 52, 72\u201378, 10.1016\/j.jhep.2009.10.001 (2010).","journal-title":"J. Hepatol."},{"key":"BFsrep13994_CR11","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/jmv.22094","volume":"83","author":"N Akuta","year":"2011","unstructured":"Akuta, N. et al. Amino acid substitutions in hepatitis C virus core region predict hepatocarcinogenesis following eradication of HCV RNA by antiviral therapy. J. Med. Virol. 83, 1016\u20131022, 10.1002\/jmv.22094 (2011).","journal-title":"J. Med. Virol."},{"key":"BFsrep13994_CR12","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/j.1348-0421.2011.00331.x","volume":"55","author":"A El-Shamy","year":"2011","unstructured":"El-Shamy, A. et al. Sequence heterogeneity of NS5A and core proteins of hepatitis C virus and virological responses to pegylated-interferon\/ribavirin combination therapy. Microbiol. Immunol. 55, 418\u2013426, 10.1111\/j.1348-0421.2011.00331.x (2011).","journal-title":"Microbiol. Immunol."},{"key":"BFsrep13994_CR13","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/j.1365-2893.2010.01305.x","volume":"18","author":"K Hayashi","year":"2011","unstructured":"Hayashi, K. et al. Mutations in the core and NS5A region of hepatitis C virus genotype 1b and correlation with response to pegylated-interferon-alpha 2b and ribavirin combination therapy. J. Viral Hepat. 18, 280\u2013286, 10.1111\/j.1365-2893.2010.01305.x (2011).","journal-title":"J. Viral Hepat."},{"key":"BFsrep13994_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000322219","volume":"55","author":"A El-Shamy","year":"2012","unstructured":"El-Shamy, A. et al. Polymorphisms of hepatitis C virus non-structural protein 5A and core protein and clinical outcome of pegylated-interferon\/ribavirin combination therapy. Intervirology 55, 1\u201311, doi: 10.1159\/000322219 (2012).","journal-title":"Intervirology"},{"key":"BFsrep13994_CR15","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1002\/hep.25949","volume":"56","author":"N Akuta","year":"2012","unstructured":"Akuta, N. et al. Complicated relationships of amino acid substitution in hepatitis C virus core region and IL28B genotype influencing hepatocarcinogenesis. Hepatology 56, 2134\u20132141, 10.1002\/hep.25949 (2012).","journal-title":"Hepatology"},{"key":"BFsrep13994_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000339993","volume":"56","author":"Y Seko","year":"2013","unstructured":"Seko, Y. et al. Amino acid substitutions in the hepatitis C Virus core region and lipid metabolism are associated with hepatocarcinogenesis in nonresponders to interferon plus ribavirin combination therapy. Intervirology 56, 13\u201321, doi: 10.1159\/000339993 (2013).","journal-title":"Intervirology"},{"key":"BFsrep13994_CR17","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/hep.26205","volume":"58","author":"A El-Shamy","year":"2013","unstructured":"El-Shamy, A. et al. Polymorphisms of the core, NS3 and NS5A proteins of hepatitis C virus genotype 1b associate with development of hepatocellular carcinoma. Hepatology 58, 555\u2013563, 10.1002\/hep.26205 (2013).","journal-title":"Hepatology"},{"key":"BFsrep13994_CR18","doi-asserted-by":"publisher","first-page":"12541","DOI":"10.1128\/JVI.00826-13","volume":"87","author":"M Miura","year":"2013","unstructured":"Miura, M. et al. Deep-sequencing analysis of the association between the quasispecies nature of the hepatitis C virus core region and disease progression. J. Virol. 87, 12541\u201312551, 10.1128\/JVI.00826-13 (2013).","journal-title":"J. Virol."},{"key":"BFsrep13994_CR19","doi-asserted-by":"publisher","first-page":"10773","DOI":"10.1073\/pnas.90.22.10773","volume":"90","author":"M Hijikata","year":"1993","unstructured":"Hijikata, M. et al. Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus. Proc. Natl. Acad. Sci. USA. 90, 10773\u201310777 (1993).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"BFsrep13994_CR20","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1128\/jvi.67.3.1385-1395.1993","volume":"67","author":"A Grakoui","year":"1993","unstructured":"Grakoui, A., Wychowski, C., Lin, C., Feinstone, S. M. & Rice, C. M. Expression and identification of hepatitis C virus polyprotein cleavage products. J. Virol. 67, 1385\u20131395 (1993).","journal-title":"J. Virol."},{"key":"BFsrep13994_CR21","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/ncb1631","volume":"9","author":"Y Miyanari","year":"2007","unstructured":"Miyanari, Y. et al. The lipid droplet is an important organelle for hepatitis C virus production. Nat. Cell Biol. 9, 1089\u20131097, 10.1038\/ncb1631 (2007).","journal-title":"Nat. Cell Biol."},{"key":"BFsrep13994_CR22","doi-asserted-by":"publisher","first-page":"7964","DOI":"10.1128\/JVI.00826-08","volume":"82","author":"T Masaki","year":"2008","unstructured":"Masaki, T. et al. Interaction of hepatitis C virus nonstructural protein 5A with core protein is critical for the production of infectious virus particles. J. Virol. 82, 7964\u20137976, 10.1128\/JVI.00826-08 (2008).","journal-title":"J. Virol."},{"key":"BFsrep13994_CR23","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1128\/jvi.70.7.4438-4443.1996","volume":"70","author":"RB Ray","year":"1996","unstructured":"Ray, R. B., Lagging, L. M., Meyer, K. & Ray, R. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J. Virol. 70, 4438\u20134443 (1996).","journal-title":"J. Virol."},{"key":"BFsrep13994_CR24","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1099\/0022-1317-78-7-1527","volume":"78","author":"K Moriya","year":"1997","unstructured":"Moriya, K. et al. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J. Gen. Virol. 78 (Pt 7), 1527\u20131531 (1997).","journal-title":"J. Gen. Virol."},{"key":"BFsrep13994_CR25","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/2053","volume":"4","author":"K Moriya","year":"1998","unstructured":"Moriya, K. et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat. Med. 4, 1065\u20131067, doi: 10.1038\/2053 (1998).","journal-title":"Nat. Med."},{"key":"BFsrep13994_CR26","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1128\/JVI.74.4.1736-1741.2000","volume":"74","author":"H Aoki","year":"2000","unstructured":"Aoki, H., Hayashi, J., Moriyama, M., Arakawa, Y. & Hino, O. Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1. J. Virol. 74, 1736\u20131741 (2000).","journal-title":"J. Virol."},{"key":"BFsrep13994_CR27","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1053\/jhep.2000.19343","volume":"32","author":"J Hayashi","year":"2000","unstructured":"Hayashi, J. et al. Hepatitis C virus core protein activates the MAPK\/ERK cascade synergistically with tumor promoter TPA, but not with epidermal growth factor or transforming growth factor alpha. Hepatology 32, 958\u2013961, 10.1053\/jhep.2000.19343 (2000).","journal-title":"Hepatology"},{"issue":"6","key":"BFsrep13994_CR28","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1053\/jhep.2000.7985","volume":"31","author":"Masao Honda","year":"2000","unstructured":"Honda, M. et al. Hepatitis C virus core protein induces apoptosis and impairs cell-cycle regulation in stably transformed Chinese hamster ovary cells. Hepatology 31, 1351-1359, 10.1053\/jhep.2000.7985 (2000).","journal-title":"Hepatology"},{"key":"BFsrep13994_CR29","doi-asserted-by":"publisher","first-page":"10237","DOI":"10.1128\/JVI.77.19.10237-10249.2003","volume":"77","author":"K Moriishi","year":"2003","unstructured":"Moriishi, K. et al. Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein. J. Virol. 77, 10237\u201310249 (2003).","journal-title":"J. Virol."},{"key":"BFsrep13994_CR30","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1053\/jhep.2003.50399","volume":"38","author":"T Tsutsumi","year":"2003","unstructured":"Tsutsumi, T. et al. Hepatitis C virus core protein activates ERK and p38 MAPK in cooperation with ethanol in transgenic mice. Hepatology 38, 820\u2013828, 10.1053\/jhep.2003.50399 (2003).","journal-title":"Hepatology"},{"key":"BFsrep13994_CR31","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.jhep.2005.03.028","volume":"43","author":"H Miyoshi","year":"2005","unstructured":"Miyoshi, H. et al. Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression. J. Hepatol. 43, 757\u2013763, 10.1016\/j.jhep.2005.03.028 (2005).","journal-title":"J. Hepatol."},{"key":"BFsrep13994_CR32","doi-asserted-by":"publisher","first-page":"11066","DOI":"10.1128\/JVI.01300-08","volume":"82","author":"T Kanda","year":"2008","unstructured":"Kanda, T., Steele, R., Ray, R. & Ray, R. B. Hepatitis C virus core protein augments androgen receptor-mediated signaling. J. Virol. 82, 11066\u201311072, 10.1128\/JVI.01300-08 (2008).","journal-title":"J. Virol."},{"key":"BFsrep13994_CR33","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/ijc.23056","volume":"122","author":"N Tanaka","year":"2008","unstructured":"Tanaka, N., Moriya, K., Kiyosawa, K., Koike, K. & Aoyama, T. Hepatitis C virus core protein induces spontaneous and persistent activation of peroxisome proliferator-activated receptor alpha in transgenic mice: implications for HCV-associated hepatocarcinogenesis. Int. J. Cancer 122, 124\u2013131, 10.1002\/ijc.23056 (2008).","journal-title":"Int. J. Cancer"},{"key":"BFsrep13994_CR34","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1099\/vir.0.015909-0","volume":"91","author":"AG Angus","year":"2010","unstructured":"Angus, A. G. et al. Requirement of cellular DDX3 for hepatitis C virus replication is unrelated to its interaction with the viral core protein. J. Gen. Virol. 91, 122\u2013132, 10.1099\/vir.0.015909-0 (2010).","journal-title":"J. Gen. Virol."},{"key":"BFsrep13994_CR35","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.jhep.2013.07.036","volume":"59","author":"N Benzoubir","year":"2013","unstructured":"Benzoubir, N. et al. HCV core-mediated activation of latent TGF-beta via thrombospondin drives the crosstalk between hepatocytes and stromal environment. J. Hepatol. 59, 1160\u20131168, 10.1016\/j.jhep.2013.07.036 (2013).","journal-title":"J. Hepatol."},{"key":"BFsrep13994_CR36","doi-asserted-by":"publisher","first-page":"e95627","DOI":"10.1371\/journal.pone.0095627","volume":"9","author":"AE Stone","year":"2014","unstructured":"Stone, A. E. et al. Hepatitis C virus core protein inhibits interferon production by a human plasmacytoid dendritic cell line and dysregulates interferon regulatory factor-7 and signal transducer and activator of transcription (STAT) 1 protein expression. PLoS One 9, e95627, 10.1371\/journal.pone.0095627 (2014).","journal-title":"PLoS One"},{"key":"BFsrep13994_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.immuni.2013.12.010","volume":"40","author":"SH Park","year":"2014","unstructured":"Park, S. H. & Rehermann, B. Immune responses to HCV and other hepatitis viruses. Immunity 40, 13\u201324, 10.1016\/j.immuni.2013.12.010 (2014).","journal-title":"Immunity"},{"key":"BFsrep13994_CR38","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/nm.3253","volume":"19","author":"SM Horner","year":"2013","unstructured":"Horner, S. M. & Gale, M., Jr. Regulation of hepatic innate immunity by hepatitis C virus. Nat. Med. 19, 879\u2013888, 10.1038\/nm.3253 (2013).","journal-title":"Nat. Med."},{"key":"BFsrep13994_CR39","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.chom.2009.11.004","volume":"6","author":"U Garaigorta","year":"2009","unstructured":"Garaigorta, U. & Chisari, F. V. Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation. Cell Host Microbe 6, 513\u2013522, 10.1016\/j.chom.2009.11.004 (2009).","journal-title":"Cell Host Microbe"},{"key":"BFsrep13994_CR40","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1053\/j.gastro.2014.01.054","volume":"146","author":"W Kang","year":"2014","unstructured":"Kang, W. et al. Hepatitis C Virus Attenuates Interferon-Induced MHC Class I Expression and Decreases CD8 T-Cell Effector Functions. Gastroenterology 146, 1351\u20131360, 10.1053\/j.gastro.2014.01.054 (2014).","journal-title":"Gastroenterology"},{"key":"BFsrep13994_CR41","doi-asserted-by":"publisher","first-page":"7555","DOI":"10.3748\/wjg.v20.i24.7555","volume":"20","author":"A El-Shamy","year":"2014","unstructured":"El-Shamy, A. & Hotta, H. Impact of hepatitis C virus heterogeneity on interferon sensitivity: an overview. World J. Gastroenterol. 20, 7555\u20137569, 10.3748\/wjg.v20.i24.7555 (2014).","journal-title":"World J. Gastroenterol."},{"key":"BFsrep13994_CR42","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nm1268","volume":"11","author":"T Wakita","year":"2005","unstructured":"Wakita, T. et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11, 791\u2013796, 10.1038\/nm1268 (2005).","journal-title":"Nat. Med."},{"key":"BFsrep13994_CR43","doi-asserted-by":"publisher","first-page":"5986","DOI":"10.1128\/jvi.02583-10","volume":"85","author":"Y Funaoka","year":"2011","unstructured":"Funaoka, Y. et al. Analysis of interferon signaling by infectious hepatitis C virus clones with substitutions of core amino acids 70 and 91. J. Virol. 85, 5986\u20135994, 10.1128\/jvi.02583-10 (2011).","journal-title":"J. Virol."},{"key":"BFsrep13994_CR44","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1111\/j.1478-3231.2010.02299.x","volume":"30","author":"F Ikeda","year":"2010","unstructured":"Ikeda, F. et al. Amino acid substitutions of hepatitis C virus core protein are not associated with intracellular antiviral response to interferon-alpha in vitro. Liver Int 30, 1324\u20131331, 10.1111\/j.1478-3231.2010.02299.x (2010).","journal-title":"Liver Int"},{"key":"BFsrep13994_CR45","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/hep.24453","volume":"54","author":"N Hiraga","year":"2011","unstructured":"Hiraga, N. et al. Impact of viral amino acid substitutions and host interleukin-28b polymorphism on replication and susceptibility to interferon of hepatitis C virus. Hepatology 54, 764\u2013771, 10.1002\/hep.24453 (2011).","journal-title":"Hepatology"},{"key":"BFsrep13994_CR46","doi-asserted-by":"publisher","first-page":"9294","DOI":"10.1073\/pnas.0503596102","volume":"102","author":"J Zhong","year":"2005","unstructured":"Zhong, J. et al. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. USA. 102, 9294\u20139299, 10.1073\/pnas.0503596102 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"BFsrep13994_CR47","doi-asserted-by":"publisher","first-page":"5036","DOI":"10.1128\/jvi.01573-06","volume":"81","author":"D Akazawa","year":"2007","unstructured":"Akazawa, D. et al. CD81 expression is important for the permissiveness of Huh7 cell clones for heterogeneous hepatitis C virus infection. J. Virol. 81, 5036\u20135045, 10.1128\/jvi.01573-06 (2007).","journal-title":"J. Virol."},{"key":"BFsrep13994_CR48","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1038\/nprot.2006.395","volume":"1","author":"T Kato","year":"2006","unstructured":"Kato, T. et al. Cell culture and infection system for hepatitis C virus. Nat. Protoc. 1, 2334\u20132339, 10.1038\/nprot.2006.395 (2006).","journal-title":"Nat. Protoc."},{"key":"BFsrep13994_CR49","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/jmv.1055","volume":"64","author":"T Kato","year":"2001","unstructured":"Kato, T. et al. Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient. J. Med. Virol. 64, 334\u2013339 (2001).","journal-title":"J. Med. Virol."},{"key":"BFsrep13994_CR50","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1128\/JCM.37.6.1802-1808.1999","volume":"37","author":"K Aoyagi","year":"1999","unstructured":"Aoyagi, K. et al. Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen. J. Clin. Microbiol. 37, 1802\u20131808 (1999).","journal-title":"J. Clin. Microbiol."},{"key":"BFsrep13994_CR51","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1128\/JCM.00487-12","volume":"50","author":"A Murayama","year":"2012","unstructured":"Murayama, A. et al. Japanese reference panel of blood specimens for evaluation of hepatitis C virus RNA and core antigen quantitative assays. J. Clin. Microbiol. 50, 1943\u20131949, 10.1128\/JCM.00487-12 (2012).","journal-title":"J. Clin. Microbiol."},{"key":"BFsrep13994_CR52","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/hep.22422","volume":"48","author":"T Kato","year":"2008","unstructured":"Kato, T. et al. Hepatitis C virus JFH-1 strain infection in chimpanzees is associated with low pathogenicity and emergence of an adaptive mutation. Hepatology 48, 732\u2013740, 10.1002\/hep.22422 (2008).","journal-title":"Hepatology"},{"key":"BFsrep13994_CR53","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/hep.24399","volume":"54","author":"M Saeed","year":"2011","unstructured":"Saeed, M. et al. In vivo adaptation of hepatitis C virus in chimpanzees for efficient virus production and evasion of apoptosis. Hepatology 54, 425\u2013433, 10.1002\/hep.24399 (2011).","journal-title":"Hepatology"}],"updated-by":[{"DOI":"10.1038\/srep17208","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T00:00:00Z","timestamp":1450224000000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep13994","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep13994.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep13994.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T19:01:21Z","timestamp":1672945281000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep13994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,14]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,11,26]]}},"alternative-id":["BFsrep13994"],"URL":"https:\/\/doi.org\/10.1038\/srep13994","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,14]]},"assertion":[{"value":"25 February 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2015","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A correction has been published and is appended to both the HTML and PDF versions of this paper. The error has been fixed in the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13994"}}